vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and QUALYS, INC. (QLYS). Click either name above to swap in a different company.

QUALYS, INC. is the larger business by last-quarter revenue ($175.3M vs $104.5M, roughly 1.7× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 10.1%). QUALYS, INC. produced more free cash flow last quarter ($74.9M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 9.6%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Qualys, Inc. is an American technology firm based in Foster City, California, specializing in cloud security, compliance and related services.

IMCR vs QLYS — Head-to-Head

Bigger by revenue
QLYS
QLYS
1.7× larger
QLYS
$175.3M
$104.5M
IMCR
Growing faster (revenue YoY)
IMCR
IMCR
+14.2% gap
IMCR
24.3%
10.1%
QLYS
More free cash flow
QLYS
QLYS
$110.5M more FCF
QLYS
$74.9M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
9.6%
QLYS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
QLYS
QLYS
Revenue
$104.5M
$175.3M
Net Profit
$53.1M
Gross Margin
97.4%
83.4%
Operating Margin
-18.8%
33.6%
Net Margin
30.3%
Revenue YoY
24.3%
10.1%
Net Profit YoY
20.9%
EPS (diluted)
$-0.61
$1.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
QLYS
QLYS
Q4 25
$104.5M
$175.3M
Q3 25
$103.7M
$169.9M
Q2 25
$98.0M
$164.1M
Q1 25
$93.9M
$159.9M
Q4 24
$84.1M
$159.2M
Q3 24
$80.2M
$153.9M
Q2 24
$75.4M
$148.7M
Q1 24
$70.5M
$145.8M
Net Profit
IMCR
IMCR
QLYS
QLYS
Q4 25
$53.1M
Q3 25
$-177.0K
$50.3M
Q2 25
$-10.3M
$47.3M
Q1 25
$5.0M
$47.5M
Q4 24
$44.0M
Q3 24
$8.7M
$46.2M
Q2 24
$-11.6M
$43.8M
Q1 24
$-24.4M
$39.7M
Gross Margin
IMCR
IMCR
QLYS
QLYS
Q4 25
97.4%
83.4%
Q3 25
99.5%
83.6%
Q2 25
98.9%
82.4%
Q1 25
99.1%
81.9%
Q4 24
99.6%
81.8%
Q3 24
99.4%
81.3%
Q2 24
97.7%
82.2%
Q1 24
99.7%
81.3%
Operating Margin
IMCR
IMCR
QLYS
QLYS
Q4 25
-18.8%
33.6%
Q3 25
-6.9%
35.3%
Q2 25
-15.2%
31.3%
Q1 25
-3.9%
32.4%
Q4 24
-23.1%
31.0%
Q3 24
-10.6%
29.2%
Q2 24
-21.2%
32.3%
Q1 24
-37.6%
30.7%
Net Margin
IMCR
IMCR
QLYS
QLYS
Q4 25
30.3%
Q3 25
-0.2%
29.6%
Q2 25
-10.5%
28.8%
Q1 25
5.4%
29.7%
Q4 24
27.6%
Q3 24
10.9%
30.0%
Q2 24
-15.4%
29.4%
Q1 24
-34.7%
27.2%
EPS (diluted)
IMCR
IMCR
QLYS
QLYS
Q4 25
$-0.61
$1.47
Q3 25
$0.00
$1.39
Q2 25
$-0.20
$1.29
Q1 25
$0.10
$1.29
Q4 24
$-0.47
$1.19
Q3 24
$0.17
$1.24
Q2 24
$-0.23
$1.17
Q1 24
$-0.49
$1.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
QLYS
QLYS
Cash + ST InvestmentsLiquidity on hand
$864.2M
$250.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$561.2M
Total Assets
$1.1B
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
QLYS
QLYS
Q4 25
$864.2M
$250.3M
Q3 25
$892.4M
$225.3M
Q2 25
$882.8M
$194.0M
Q1 25
$837.0M
$290.7M
Q4 24
$820.4M
$232.2M
Q3 24
$901.3M
$235.4M
Q2 24
$859.6M
$281.2M
Q1 24
$832.8M
$273.8M
Total Debt
IMCR
IMCR
QLYS
QLYS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
QLYS
QLYS
Q4 25
$381.0M
$561.2M
Q3 25
$396.6M
$529.4M
Q2 25
$388.5M
$508.2M
Q1 25
$378.5M
$498.0M
Q4 24
$360.7M
$477.1M
Q3 24
$377.8M
$449.6M
Q2 24
$359.1M
$427.8M
Q1 24
$359.5M
$404.2M
Total Assets
IMCR
IMCR
QLYS
QLYS
Q4 25
$1.1B
$1.1B
Q3 25
$1.1B
$1.0B
Q2 25
$1.1B
$999.5M
Q1 25
$1.0B
$996.5M
Q4 24
$1.0B
$973.5M
Q3 24
$1.1B
$908.3M
Q2 24
$1.0B
$876.6M
Q1 24
$994.0M
$861.8M
Debt / Equity
IMCR
IMCR
QLYS
QLYS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
QLYS
QLYS
Operating Cash FlowLast quarter
$-32.7M
$75.7M
Free Cash FlowOCF − Capex
$-35.5M
$74.9M
FCF MarginFCF / Revenue
-34.0%
42.8%
Capex IntensityCapex / Revenue
2.8%
0.4%
Cash ConversionOCF / Net Profit
1.42×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$304.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
QLYS
QLYS
Q4 25
$-32.7M
$75.7M
Q3 25
$-4.5M
$90.4M
Q2 25
$26.0M
$33.8M
Q1 25
$435.0K
$109.6M
Q4 24
$-14.0M
$47.7M
Q3 24
$21.1M
$61.0M
Q2 24
$23.5M
$49.8M
Q1 24
$-4.6M
$85.5M
Free Cash Flow
IMCR
IMCR
QLYS
QLYS
Q4 25
$-35.5M
$74.9M
Q3 25
$-5.2M
$89.5M
Q2 25
$25.6M
$32.4M
Q1 25
$137.0K
$107.5M
Q4 24
$-17.5M
$41.9M
Q3 24
$20.3M
$57.6M
Q2 24
$23.1M
$48.8M
Q1 24
$-5.0M
$83.5M
FCF Margin
IMCR
IMCR
QLYS
QLYS
Q4 25
-34.0%
42.8%
Q3 25
-5.0%
52.7%
Q2 25
26.1%
19.8%
Q1 25
0.1%
67.3%
Q4 24
-20.9%
26.3%
Q3 24
25.3%
37.4%
Q2 24
30.7%
32.8%
Q1 24
-7.1%
57.2%
Capex Intensity
IMCR
IMCR
QLYS
QLYS
Q4 25
2.8%
0.4%
Q3 25
0.7%
0.5%
Q2 25
0.4%
0.8%
Q1 25
0.3%
1.3%
Q4 24
4.3%
3.7%
Q3 24
1.0%
2.2%
Q2 24
0.4%
0.7%
Q1 24
0.6%
1.4%
Cash Conversion
IMCR
IMCR
QLYS
QLYS
Q4 25
1.42×
Q3 25
1.80×
Q2 25
0.71×
Q1 25
0.09×
2.31×
Q4 24
1.09×
Q3 24
2.42×
1.32×
Q2 24
1.14×
Q1 24
2.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

QLYS
QLYS

Sales Channel Through Intermediary$88.6M51%
Sales Channel Directly To Consumer$86.7M49%

Related Comparisons